Skip header and navigation

Narrow By

44 records – page 2 of 3.

Azathioprine and Mercaptopurine Therapy

https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1079
Available Online
View Pamphlet
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Azathioprine
Mercaptopurine
Subjects (LCSH)
Immunosuppressive agents
Specialty
Medications
Abstract
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Notes
Previous title: Azathioprine (Imuran) therapy
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1079
Less detail
Nova Scotia Health Authority. QEII. GI/General Surgery staff. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0046
Available Online
View Pamphlet
Your doctor has arranged for you to have bowel surgery. During surgery, a part of your bowel will be removed. This pamphlet will answer some of your questions about your stay in the hospital and care at home. An overview of what will happen before and after surgery is provided. Topics include: activity after surgery, nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your p…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI/General Surgery staff
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Intestines - surgery
Colectomy
Colostomy
Subjects (LCSH)
Intestines--Surgery
Colectomy
Colostomy
Abstract
Your doctor has arranged for you to have bowel surgery. During surgery, a part of your bowel will be removed. This pamphlet will answer some of your questions about your stay in the hospital and care at home. An overview of what will happen before and after surgery is provided. Topics include: activity after surgery, nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your primary health care provider are listed.
Responsibility
Prepared by: GI/General Surgery staff
Pamphlet Number
0046
Less detail

Laparoscopic bowel surgery

https://libcat.nshealth.ca/en/permalink/chpams35662
Nova Scotia Health Authority. QEII. GI/General Surgery staff. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0933
Available Online
View Pamphlet
Your doctor has arranged for you to have laparoscopic bowel surgery. During surgery, a part of your bowel will be removed using a laparoscope. Laparoscopic surgery has fewer complications than open bowel surgery. An overview of what will happen before and after surgery is provided. Topics include: nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your primary health care p…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI/General Surgery staff
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Intestines - surgery
Laparoscopy
Subjects (LCSH)
Intestines--Surgery
Laparoscopic surgery
Abstract
Your doctor has arranged for you to have laparoscopic bowel surgery. During surgery, a part of your bowel will be removed using a laparoscope. Laparoscopic surgery has fewer complications than open bowel surgery. An overview of what will happen before and after surgery is provided. Topics include: nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your primary health care provider are listed.
Responsibility
Prepared by: GI/General Surgery staff
Pamphlet Number
0933
Less detail

VRE (vancomycin-resistant enterococcus)

https://libcat.nshealth.ca/en/permalink/chpams35798
Nova Scotia Health Authority. Infection Prevention and Control. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1752
Available Online
View Pamphlet
Enterococci (plural of enterococcus) are bacteria that are commonly found in our bowel (gut). If enterococci travel to other parts of the body, they can cause an infection and make you sick. Antibiotics (such as vancomycin) are medications used to treat infections. Sometimes enterococci bacteria become unable to be destroyed by vancomycin or other antibiotics. When this happens, the bacteria are called resistant to vancomycin, and are known as vancomycin-resistant enterococcus (VRE). This pamph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Infection Prevention and Control
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Vancomycin-Resistant Enterococci
Subjects (LCSH)
Enterococcus
Drug resistance in microorganisms
Specialty
Infectious Diseases
Abstract
Enterococci (plural of enterococcus) are bacteria that are commonly found in our bowel (gut). If enterococci travel to other parts of the body, they can cause an infection and make you sick. Antibiotics (such as vancomycin) are medications used to treat infections. Sometimes enterococci bacteria become unable to be destroyed by vancomycin or other antibiotics. When this happens, the bacteria are called resistant to vancomycin, and are known as vancomycin-resistant enterococcus (VRE). This pamphlet identifies how VRE is spread, screening for VRE, care in hospital and at home, and infection prevention and control (IPAC) guidelines to prevent spreading VRE. The French version of this pamphlet 1857, "ERV (Entérocoques résistants à la vancomycine)", is also available.
Responsibility
Prepared by: Infection Prevention and Control
Pamphlet Number
1752
Less detail

ERV (Entérocoques résistants à la vancomycine)

https://libcat.nshealth.ca/en/permalink/chpams35923
Nova Scotia Health Authority. Infection Prevention and Control. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1857
Available Online
View Pamphlet
Les entérocoques sont des bactéries souvent présentes dans notre intestin. Lorsque les entérocoques se déplacent vers d’autres parties du corps, ils peuvent provoquer une infection et rendre malade. Les antibiotiques, comme la vancomycine, sont des médicaments utilisés pour traiter certaines infections. Les entérocoques développent parfois une résistance à la vancomycine ou à d’autres antibiotiques. Quand cela se produit, on dit que les bactéries sont « résistantes » à la vancomycine et on parl…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Infection Prevention and Control
Alternate Title
VRE (Vancomycin-resistant enterococcus)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Vancomycin-Resistant Enterococci
Subjects (LCSH)
Enterococcus
Drug resistance in microorganisms
Specialty
Infectious Diseases
Abstract
Les entérocoques sont des bactéries souvent présentes dans notre intestin. Lorsque les entérocoques se déplacent vers d’autres parties du corps, ils peuvent provoquer une infection et rendre malade. Les antibiotiques, comme la vancomycine, sont des médicaments utilisés pour traiter certaines infections. Les entérocoques développent parfois une résistance à la vancomycine ou à d’autres antibiotiques. Quand cela se produit, on dit que les bactéries sont « résistantes » à la vancomycine et on parle des entérocoques résistants à la vancomycine, ou ERV. Ce dépliant explique comment une personne contracte des ERV, comment on les détecte, les soins dispensés à l’hôpital et à la maison et la façon de prévenir la transmission des ERV.
This pamphlet is a French translation of "VRE (Vancomycin-resistant Enterococcus)" pamphlet 1752. Enterococci (plural of enterococcus) are bacteria that are commonly found in our bowel (gut). If enterococci travel to other parts of the body, they can cause an infection and make you sick. Antibiotics (such as vancomycin) are medications used to treat infections. Sometimes enterococci bacteria become unable to be destroyed by vancomycin or other antibiotics. When this happens, the bacteria are called resistant to vancomycin, and are known as vancomycin-resistant enterococcus (VRE). This pamphlet identifies how VRE is spread, screening for VRE, care in hospital and at home, and infection prevention and control (IPAC) guidelines to prevent spreading VRE.
Responsibility
Prepared by: Infection Prevention and Control
Pamphlet Number
1857
Less detail

What to eat after whipple surgery

https://libcat.nshealth.ca/en/permalink/chpams37492
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1366
Available Online
View Pamphlet
During Whipple surgery, parts of the stomach, small bowel, gallbladder, and pancreas are removed. These organs are important for digesting food. After surgery you may need to make some changes to your eating habits. Following the tips in this guide can help you get the nutrition you need to heal, feel comfortable during the first 4 weeks (1 month) after surgery, and keep or gain weight after surgery. Foods that are best tolerated and foods to avoid are listed. Other topics include whether you w…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Gastrointestinal Diseases - diet therapy
Postoperative Care
Subjects (LCSH)
Postoperative care
Gastrointestinal system
Specialty
Food and Nutrition
Abstract
During Whipple surgery, parts of the stomach, small bowel, gallbladder, and pancreas are removed. These organs are important for digesting food. After surgery you may need to make some changes to your eating habits. Following the tips in this guide can help you get the nutrition you need to heal, feel comfortable during the first 4 weeks (1 month) after surgery, and keep or gain weight after surgery. Foods that are best tolerated and foods to avoid are listed. Other topics include whether you will need to take pancreatic enzymes, what to do if your stomach is slow to empty, what to do if you get dumping syndrome, whether you will need to take vitamins after surgery, and what to do if you are losing weight. Recipes are included.
Responsibility
Nutrition and Food Services
Pamphlet Number
1366
Less detail

Clostridioides difficile (C. diff)

https://libcat.nshealth.ca/en/permalink/chpams34806
Nova Scotia Health Authority. Infection Prevention and Control. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0602
Available Online
View Pamphlet
Clostridioides difficile (C. diff) is a type of bacteria (germ) that is found in the intestine (gut or bowel). This pamphlet explains how you get C. diff, symptoms, treatment, and how you can prevent spreading it to others. If you would like more information, please ask your health care provider or ask to talk with an Infection Prevention and Control (IPAC) Practitioner. The French version of this pamphlet 1852, "Clostridioides difficile (C. difficile)", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Infection Prevention and Control
Alternate Title
C.diff
C. difficile
Cdiff
Cdifficile
CDI
Gastroenteritis
Diarrhea
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Infectious diseases
Clostridioides difficile
Subjects (LCSH)
Clostridium difficile
Diarrhea
Gastroenteritis
Specialty
Infectious Diseases
Abstract
Clostridioides difficile (C. diff) is a type of bacteria (germ) that is found in the intestine (gut or bowel). This pamphlet explains how you get C. diff, symptoms, treatment, and how you can prevent spreading it to others. If you would like more information, please ask your health care provider or ask to talk with an Infection Prevention and Control (IPAC) Practitioner. The French version of this pamphlet 1852, "Clostridioides difficile (C. difficile)", is also available.
Notes
Previous title: Clostridium difficile (C. diff)
Responsibility
Prepared by: Infection Prevention and Control
Pamphlet Number
0602
Less detail

Infliximab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34944
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1140
Available Online
View Pamphlet
Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Infliximab
Subjects (LCSH)
Inflammatory bowel diseases
Infliximab
Abstract
Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Infliximab (Remicade) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1140
Less detail

Adalimumab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1207
Available Online
View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Adalimumab (Humira) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1207
Less detail

Getting ready for a computed tomography (CT) virtual colonscopy : QEII Health Sciences Centre, Dartmouth General Hospital, Cobequid Community Health Centre

https://libcat.nshealth.ca/en/permalink/chpams35252
Nova Scotia Health Authority. QEII Health Sciences Centre. Diagnostic Imaging, Nova Scotia Health Authority. Dartmouth General Hospital. Diagnostic Imaging, Nova Scotia Health Authority. Cobequid Community Health Centre. Diagnostic Imaging. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1370
Available Online
View Pamphlet
A virtual colonoscopy (VC) is a test used to check the inside lining of the colon for growths called polyps. It is also called a computerized tomography (CT) colonography or CTC. This pamphlet explains how to get ready for a CT VC, including instructions to make sure your bowel is properly cleaned for the test, and what will happen during the test.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII Health Sciences Centre. Diagnostic Imaging
Nova Scotia Health Authority. Dartmouth General Hospital. Diagnostic Imaging
Nova Scotia Health Authority. Cobequid Community Health Centre. Diagnostic Imaging
Alternate Title
CT colonography
CTC
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Colonography, Computed Tomographic
Subjects (LCSH)
Colon (Anatomy)--Tomography
Specialty
Diagnostic Imaging
Abstract
A virtual colonoscopy (VC) is a test used to check the inside lining of the colon for growths called polyps. It is also called a computerized tomography (CT) colonography or CTC. This pamphlet explains how to get ready for a CT VC, including instructions to make sure your bowel is properly cleaned for the test, and what will happen during the test.
Notes
previous title: Getting ready for a CT virtual colonscopy : QEII, DGH, CCHC
Responsibility
Prepared by: Diagnostic Imaging, QEII, DGH, CCHC
Pamphlet Number
1370
Less detail

5-Aminosalicylate (5-ASA) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35397
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1483
Available Online
View Pamphlet
5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Crohn Disease - drug therapy
Colitis - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Colitis
Abstract
5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.
Notes
Previous title: 5-Aminosalicylate (5-ASA)
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1483
Less detail

Vedolizumab (Entyvio) therapy

https://libcat.nshealth.ca/en/permalink/chpams35620
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1623
Available Online
View Pamphlet
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when und…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Gastrointestinal Agents
Colitis, Ulcerative - drug therapy
Crohn Disease - drug therapy
Subjects (LCSH)
Gastrointestinal agents
Ulcerative colitis
Crohn's disease
Specialty
Medications
Abstract
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when undergoing this treatment are provided.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1623
Less detail

Golimumab (Simponi®) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1641
Available Online
View Pamphlet
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Golimumab (Simponi) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1641
Less detail

Ustekinumab (Stelara) therapy

https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1695
Available Online
View Pamphlet
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ustekinumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Ulcerative colitis
Specialty
Medications
Abstract
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taking ustekinumab and while you are taking it are listed. Possible side effects, information about pregnancy and breast/chest feeding, and other important things to know are included.
Notes
Previous title: Ustekinumab (Stelara) therapy for Crohn's disease
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1695
Less detail

Clostridium difficile (C. difficile)

https://libcat.nshealth.ca/en/permalink/chpams35926
Nova Scotia Health Authority. Infection Prevention and Control. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1852
Available Online
View Pamphlet
Le Clostridioides difficile (C. difficile) est un type de bactérie (microbe) que l’on trouve dans l’intestin. La présente brochure explique comment l’on contracte une infection à C. difficile, les symptômes, le traitement et la façon de prévenir la propagation aux autres. Si vous souhaitez obtenir plus d'information, adressez-vous à votre prestataire de soins de santé ou demandez à parler à la personne responsable de la prévention et du contrôle des infections (PCI). ; This pamphlet is a French…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Infection Prevention and Control
Alternate Title
Clostridium difficile (C. diff)
C. difficile
Cdiff
Cdifficile
CDI
Gastroenteritis
Diarrhea
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Infectious diseases
Clostridium difficile
Subjects (LCSH)
Clostridium difficile
Diarrhea
Gastroenteritis
Specialty
Infectious Diseases
Abstract
Le Clostridioides difficile (C. difficile) est un type de bactérie (microbe) que l’on trouve dans l’intestin. La présente brochure explique comment l’on contracte une infection à C. difficile, les symptômes, le traitement et la façon de prévenir la propagation aux autres. Si vous souhaitez obtenir plus d'information, adressez-vous à votre prestataire de soins de santé ou demandez à parler à la personne responsable de la prévention et du contrôle des infections (PCI).
This pamphlet is a French translation of "Clostridioides difficile (C. diff)" pamphlet 0602. Clostridioides difficile (C. diff) is a type of bacteria (germ) that is found in the intestine (gut or bowel). This pamphlet explains how you get C. diff, symptoms, treatment, and how you can prevent spreading it to others. If you would like more information, please ask your health care provider or ask to talk with an Infection Prevention and Control (IPAC) Practitioner.
Notes
Previous title: Clostridium difficile (C. difficile)
Responsibility
Prepared by: Infection Prevention and Control
Pamphlet Number
1852
Less detail
Nova Scotia Health Authority. General Radiography Modality Advisory Provincial Committee. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2264
Available Online
View Pamphlet
X-rays are the most common type of diagnostic imaging test. They can be used to identify a fractured bone, a chest infection, something blocking the bowel, and more. Topics include: who will do the X-ray, how long it will take, what happens during, and what to do if you are pregnant. A list of additional resources is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. General Radiography Modality Advisory Provincial Committee
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
X-Rays
Subjects (LCSH)
X-rays
Specialty
Diagnostic Imaging
Abstract
X-rays are the most common type of diagnostic imaging test. They can be used to identify a fractured bone, a chest infection, something blocking the bowel, and more. Topics include: who will do the X-ray, how long it will take, what happens during, and what to do if you are pregnant. A list of additional resources is provided.
Responsibility
Prepared by: General Radiography Modality Advisory Provincial Committee
Pamphlet Number
2264
Less detail

Nutrition guidelines for irritable bowel syndrome (IBS)

https://libcat.nshealth.ca/en/permalink/chpams37558
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0129
Available Online
View Pamphlet
Irritable Bowel Syndrome (IBS) is a change in how food and digestive juices move through the bowels. This can be too fast, too slow, or both too fast and too slow. This pamphlet explains the symptoms of IBS, how it is treated, and what you can do to help your symptoms. Information about keeping a food symptom diary is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (16 p.) : digital, PDF file
Subjects (MeSH)
Irritable Bowel Syndrome - diet therapy
Subjects (LCSH)
Irritable colon
Abstract
Irritable Bowel Syndrome (IBS) is a change in how food and digestive juices move through the bowels. This can be too fast, too slow, or both too fast and too slow. This pamphlet explains the symptoms of IBS, how it is treated, and what you can do to help your symptoms. Information about keeping a food symptom diary is included.
Notes
Previous title: Diet & Irritable Bowel Syndrome (IBS)
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0129
Less detail

Sexual health after spinal cord injury

https://libcat.nshealth.ca/en/permalink/chpams37612
Nova Scotia Health Authority. Neurology, Nova Scotia Health Authority. Spinal Cord Injury Rehabilitation Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2302
Available Online
View Pamphlet
After spinal cord injury (SCI), you may have a lot of questions about your sexual health. Your rehabilitation (rehab) team is available to talk with you about any questions or concerns you may have. This pamphlet answers common questions, like whether you can still have sex, whether you will be able to have an erection or have vaginal lubrication (vagina becomes slippery to get ready for sex), whether you can still have an orgasm, how to manage bladder and/or bowel issues during sex, whether yo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Neurology
Nova Scotia Health Authority. Spinal Cord Injury Rehabilitation Program
Alternate Title
Sexual health after a spinal cord injury (SCI)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Sexual Health
Spinal cord injuries
Subjects (LCSH)
Sexual health
Spinal cord--Wounds and injuries--Patients
Specialty
Nervous System
Abstract
After spinal cord injury (SCI), you may have a lot of questions about your sexual health. Your rehabilitation (rehab) team is available to talk with you about any questions or concerns you may have. This pamphlet answers common questions, like whether you can still have sex, whether you will be able to have an erection or have vaginal lubrication (vagina becomes slippery to get ready for sex), whether you can still have an orgasm, how to manage bladder and/or bowel issues during sex, whether you are still able to have children, and how to talk about sex and intimacy with your partner. A list of online resources, as well as resources in Nova Scotia, are included.
Responsibility
Prepared by: Neurology and Spinal Cord Injury Rehabilitation Program
Pamphlet Number
2302
Less detail

Planning for your hospital stay after surgery : Halifax Infirmary (HI), Victoria General (VG), Dartmouth General Hospital (DGH)

https://libcat.nshealth.ca/en/permalink/chpams35459
Nova Scotia Health Authority. Central Zone. Same Day Surgery Unit - Halifax Infirmary, Nova Scotia Health Authority. Central Zone. Same Day Surgery Unit - Victoria General, Nova Scotia Health Authority. Central Zone. Same Day Surgery Unit - Dartmouth General Hospital. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1395
Available Online
View Pamphlet
This pamphlet gives information about your care before and after surgery. Topics about getting ready for surgery include learning about the time of your surgery, dentures and oral appliances, glasses and contact lenses, hearing aids, personal care items, and valuables. Information about the day of surgery includes what to bring to the hospital, when to arrive, anesthetic, delays, the Same Day Surgery Unit, and surgery. Information about after your surgery includes the recovery area and nursing …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Same Day Surgery Unit - Halifax Infirmary
Nova Scotia Health Authority. Central Zone. Same Day Surgery Unit - Victoria General
Nova Scotia Health Authority. Central Zone. Same Day Surgery Unit - Dartmouth General Hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (22 p.) : digital, PDF file
Subjects (MeSH)
Hospitalization
Preoperative Care
Postoperative Care
Subjects (LCSH)
Hospital patients
Preoperative care
Postoperative care
Specialty
Surgery
Abstract
This pamphlet gives information about your care before and after surgery. Topics about getting ready for surgery include learning about the time of your surgery, dentures and oral appliances, glasses and contact lenses, hearing aids, personal care items, and valuables. Information about the day of surgery includes what to bring to the hospital, when to arrive, anesthetic, delays, the Same Day Surgery Unit, and surgery. Information about after your surgery includes the recovery area and nursing unit, pain control, exercises, activity, nutrition, passing urine, and bowel movements. Instructions for your surgery and care at home include visitors and discharge from the hospital. The French version of this pamphlet 1118, "Planification de votre séjour à l'hôpital après une chirurgie", is also available.
Notes
Previous title: Planning for your hospital stay after surgery
Previous title: Planning for your hospital stay after surgery : Halifax Infirmary (HI), Victoria General Hospital (VG), Dartmouth General Hospital (DGH)
Responsibility
Prepared by: Same Day Surgery Units (HI, VG and DGH sites)
Pamphlet Number
1395
Less detail

Your craniotomy surgery : Halifax Infirmary (HI)

https://libcat.nshealth.ca/en/permalink/chpams36566
Nova Scotia Health Authority. QEII. Neurosurgery. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0589
Available Online
View Pamphlet
This pamphlet provides information about your care before and right after your craniotomy. The word craniotomy means “opening of the skull.” Topics about preparing for surgery include: blood tests, anesthetist visit, and consent. Topics about the morning of your surgery include: hair, how the surgery is done, and tissue for testing. After surgery topics include: returning to the unit, deep breathing exercises, routine checks, nutrition, bowel and bladder care, your incision, hygiene, activity a…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Neurosurgery
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Craniotomy
Brain - surgery
Subjects (LCSH)
Craniotomy
Brain--Surgery
Abstract
This pamphlet provides information about your care before and right after your craniotomy. The word craniotomy means “opening of the skull.” Topics about preparing for surgery include: blood tests, anesthetist visit, and consent. Topics about the morning of your surgery include: hair, how the surgery is done, and tissue for testing. After surgery topics include: returning to the unit, deep breathing exercises, routine checks, nutrition, bowel and bladder care, your incision, hygiene, activity and therapy, comfort, pain management, and symptoms to tell your nurse about. Rehabilitation and a list of symptoms to watch for after you go home are also listed.
Notes
Previous title: Your craniotomy
Responsibility
Prepared by: 7.3 Neurosurgery Unit, HI, QEIl
Pamphlet Number
0589
Less detail

44 records – page 2 of 3.